Chemed CORP Form 4 insider transactions

CHEMED Corp. Director Andrea R. Lindell reported gifting 463 shares of company capital stock, reducing her direct beneficial ownership to 5,539 shares.

CHEMED Corp's President and CEO, Kevin J. McNamara, sold 2,000 shares of company capital stock at a weighted average price of $437.55.

CHEMED Executive Vice President Spencer S. Lee reported gifting 60 shares of company capital stock on November 19, 2025.

CHEMED Corp. CEO of Vitas Healthcare, Joel L. Wherley, was granted 17,476 stock options with an exercise price of $443.79, vesting over three years.

CHEMED Corp's Executive Vice President, Spencer S. Lee, acquired 12,759 stock options with an exercise price of $443.79 under a Rule 10b5-1 plan.

CHEMED Corp.'s VP and Chief Legal Officer, Brian C. Judkins, was granted 15,017 stock options with an exercise price of $443.79, vesting over three years.

CHEMED Corp.'s VP & Chief Financial Officer, Michael D. Witzeman, was granted 19,486 stock options with an exercise price of $443.79, vesting over three years.

CHEMED Corp. Vice President Thomas C. Hutton acquired 6,338 stock options with an exercise price of $443.79, vesting annually starting October 21, 2026.

CHEMED Corp. President and CEO Kevin J. McNamara was granted 58,672 stock options at an exercise price of $443.79, vesting over three years.

CHEMED Corp.'s President and CEO, Kevin J. McNamara, reported the sale of 3,000 shares of company capital stock on September 26, 2025, under a Rule 10b5-1 trading plan.

CHEMED Corp. Director Patrick P. Grace sold 150 shares of common stock for $463.39 per share on September 9, 2025, under a Rule 10b5-1 plan.

CHEMED Corp's President and CEO, Kevin J. McNamara, sold 2,000 shares of company capital stock on August 5, 2025, for a weighted average price of $428.55 per share.

CHEMED Corp. Director George J. Walsh III acquired 200 shares of company capital stock at $417.1 per share under a 10b5-1 plan.

Chemed Corp Executive Vice President Nicholas Westfall sold 10,012 shares of company capital stock for approximately $4.22 million.

Director George J. Walsh III acquired 277 shares of Chemed Corp stock at $579.04 per share on May 19, 2025.

John Meredith Mount Jr., a director at Chemed Corp, acquired 277 shares of capital stock at $579.04 per share on May 19, 2025.

Director Eileen P. McCarthy reports the acquisition of 277 shares of Chemed Corp capital stock on May 19, 2025.

Director Andrea R. Lindell acquired 277 shares of Chemed Corp capital stock at $579.04 per share on May 19, 2025.

Director Christopher J. Heaney acquired 277 shares of Chemed Corp capital stock at $579.04 per share on May 19, 2025, increasing his direct holdings to 2,389 shares.

Director Patrick P. Grace acquired 277 shares of Chemed Corp capital stock on May 19, 2025, at a price of $579.04 per share.

Director Ron DeLyons acquired 277 shares of Chemed Corp capital stock at a price of $579.04 on May 19, 2025.

Executive Vice President Spencer S. Lee of Chemed Corp. reports selling 1,500 shares of capital stock at an average price of $577.99 on May 16, 2025.

Executive Vice President Nicholas Michael Westfall reports exercising stock options and disposing of shares of Chemed Corp on May 9, 2025.

Executive Vice President Spencer S. Lee of Chemed Corp sold 1,500 shares of capital stock at an average price of $577.86 on May 7, 2025.

Chemed Corp's CEO, Kevin McNamara, exercised stock options and sold shares on May 5, 2025, according to a Form 4 filing with the SEC.

Chemed Corp's CEO, Kevin J. McNamara, sold 1,000 shares of capital stock at an average price of $615.33 on March 31, 2025.

Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, exercised stock options and sold shares to cover the purchase price and tax obligations.

Chemed Corp's CEO, Kevin J. McNamara, sold 2,000 shares of capital stock at an average price of $593.67 on March 6, 2025.

Executive Vice President Spencer S. Lee of Chemed Corp reports selling 1,326 shares of capital stock at an average price of $592.25 on March 3, 2025.

Executive Vice President Spencer S. Lee reports acquisition and disposal of Chemed Corp stock and performance stock units related to performance-based vesting.